Medical device firm UltraGuide this month brought its UltraGuide 1000 ultrasound-guided interventional procedure tool to market. The Israeli firm developed the device for biopsies and treatments of abdominal organs and breast interventions, as well as
Medical device firm UltraGuide this month brought its UltraGuide 1000 ultrasound-guided interventional procedure tool to market. The Israeli firm developed the device for biopsies and treatments of abdominal organs and breast interventions, as well as cardiology, ob/gyn, and prenatal procedures. The device was cleared by the Food and Drug Administration in February of last year and is priced at about $45,000 (SCAN 6/24/98).
Study: AI Bolsters Sensitivity for Pneumothorax on CXR and Significantly Reduces Reporting Time
October 30th 2024For clinically actionable pneumothorax, an artificial intelligence algorithm demonstrated a 93 percent AUC and a 96 percent specificity rate in a study involving chest X-rays from over 27,000 adults.
AI Segmentation, Intraprostatic Tumor Volume and Metastases: What a New mpMRI Study Reveals
October 29th 2024For patients who received radiotherapy for localized prostate cancer, total intraprostatic tumor volume derived from AI segmentation had a 10 percent higher AUC for predicting seven-year metastases in comparison to a risk model from the National Comprehensive Cancer Network (NCCN).